glp-1 and general anesthesia 🔸 Should RAs be continued preprocedurally? 🔸 Who should stop a GLP-1 RA preoperatively? 🔸 Which patients should have their procedures postponed? Read: https://doi.org/10.1097/01.ASM.0001125664.22893.9f How Indian Pharma is Sauces Quantity:Triple-Pack ($99)

glp-1 and general anesthesia 🔸 Should RAs be continued preprocedurally? 🔸 Who should stop a GLP-1 RA preoperatively? 🔸 Which patients should have their procedures postponed? Read: https://doi.org/10.1097/01.ASM.0001125664.22893.9f How Indian Pharma is Sauces Quantity:Triple-Pack ($99)

How Indian Pharma is eyeing the GLP-1 opportunity | The Daily Brief #292

( a ) SAD participant flow chart (CONSORT diagram)

Sauces

Quantity:Triple-Pack ($99)

These treatment patterns need to change.” Meanwhile, more data on tirzepatide’s impact on a broad five-component cardiovascular end point — including all-cause mortality — are expected from the placebo-controlled SURMOUNT-MMO outcome trial in 15,000 patients with obesity but no diabetes